dual antiplatelet therapy (DAPT)
Showing 1 - 25 of >10,000
Percutaneous Intervention Trial in Shatin (Orsiro Mission, Resolute Onyx)
Recruiting
- Percutaneous Intervention
- Orsiro Mission
- Resolute Onyx
-
Shatin, Hong KongThe Chinese University of Hong Kong
Sep 19, 2022
Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease Trial in Bern (Algorithm-guided
Not yet recruiting
- Percutaneous Coronary Intervention
- +2 more
- Algorithm-guided DAPT duration
- Standard-of-care DAPT duration
-
Bern, SwitzerlandBern University Hospital
Feb 16, 2023
Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)
Not yet recruiting
- Elevated Lipoprotein(a) Level
- +3 more
- 24 Months DAPT
- 12 Months DAPT
-
Beijing, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Chi
Aug 26, 2023
Coronary Artery Disease Trial (Angiolite: Sirolimus-eluting stent, Xience: Sirolimus-eluting stent, 1-month DAPT)
Not yet recruiting
- Coronary Artery Disease
- Angiolite: Sirolimus-eluting stent
- +3 more
- (no location specified)
Jul 11, 2023
Acute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease Trial in Kyoto (1-months DAPT, 12-month DAPT)
Active, not recruiting
- Acute Coronary Syndrome
- +4 more
- 1-months DAPT
- 12-month DAPT
-
Kyoto, JapanKyoto University Graduate School of Medicine
Dec 18, 2021
Acute Coronary Syndrome Trial in Kyoto (No aspirin, 1-month DAPT)
Recruiting
- Acute Coronary Syndrome
- No aspirin
- 1-month DAPT
-
Kyoto, JapanKyoto University Graduate School of Medicine
Nov 16, 2022
Acute Coronary Syndrome, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)
Recruiting
- Acute Coronary Syndrome
- +2 more
- Genoss DES™ stent
-
Wonju, Gangwon State, Korea, Republic ofWonju Severance Christian Hospital
Oct 4, 2023
Coronary Artery Disease, Myocardial Infarction Trial in Ottawa (Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81
Suspended
- Coronary Artery Disease
- Myocardial Infarction
- Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily
- +2 more
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Feb 17, 2022
Coronary Artery Disease Trial in Kyoto (1-month DAPT, 12-month DAPT)
Active, not recruiting
- Coronary Artery Disease
- 1-month DAPT
- 12-month DAPT
-
Kyoto, JapanDivision of Cardiology, Kyoto University Hospital
Jan 10, 2022
Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin Trial in Shinjuku (Aspirin group, Non-antithrombotic
Recruiting
- Aortic Stenosis
- +4 more
- Aspirin group
- Non-antithrombotic group
-
Shinjuku, Tokyo, JapanKeio University Hospital
Aug 17, 2023
Coronary Artery Disease, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy Trial in Wonju (Genoss DES™ stent)
Recruiting
- Coronary Artery Disease
- +2 more
- Genoss DES™ stent
-
Wŏnju, Gangwon State, Korea, Republic ofWonju Severance Christian Hospital
Oct 4, 2023
Coronary Artery Disease Trial in Seoul (1 Month vs. 12 Months DAPT)
Recruiting
- Coronary Artery Disease
- 1 Month vs. 12 Months DAPT
-
Seoul, Korea, Republic ofSeoul St. Mary's Hospital
Mar 5, 2023
Left Main Coronary Artery Stenosis Trial in Geneva (LMCA PCI with Biofreedom Ultra drug-coated stent (Biosensors International,
Not yet recruiting
- Left Main Coronary Artery Stenosis
- LMCA PCI with Biofreedom Ultra drug-coated stent (Biosensors International, Switzerland)
- +2 more
-
Geneva, SwitzerlandGeneva University Hospitals
Jan 12, 2023
MACCE According to Time Interval of Taking Medication in Acute
Completed
- Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
- Esomezol Cap
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Aug 2, 2022
Left Atrial Appendage Occlusion Trial in Barcelona (Apixaban vs. DAPT)
Completed
- Left Atrial Appendage Occlusion
- Apixaban vs. DAPT
-
Barcelona, SpainHospital Clinic Barcelona
Nov 21, 2022
ST Elevation Myocardial Infarction Trial in Geneva (Successful primary PCI, defined as primary PCI of the culprit lesion with =1
Not yet recruiting
- ST Elevation Myocardial Infarction
- Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
-
Geneva, SwitzerlandGeneva University Hospitals
Mar 25, 2023
Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction Trial in Korea, Republic of (CX-ISAR, Orsiro,
Completed
- Stable Angina
- +2 more
- 3-months DAPT
- 1-year DAPT
-
Busan, Korea, Republic of
- +11 more
Jan 8, 2023
Coronary Artery Disease Trial in Rome (Ticagrelor, acetylsalicylic acid)
Recruiting
- Coronary Artery Disease
- Ticagrelor
- acetylsalicylic acid
-
Rome, ItalyUniversità Campus Bio-Medico di Roma
Jul 19, 2022
Coronary Artery Disease Trial in Seoul (Type of stent, Duration of DAPT)
Recruiting
- Coronary Artery Disease
- Type of stent
- Duration of DAPT
-
Seoul, Korea, Republic ofSamsung Medical Center
May 8, 2022
Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)
Recruiting
- Clopidogrel, Poor Metabolism of
- Carotid Stenosis
-
San Donato Milanese, Milan, ItalyIRCCS Policlinico San Donato
Sep 30, 2022
ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy Trial in Dordrecht, Rotterdam (Prasugrel based short DAPT,
Recruiting
- ST Elevated Myocardial Infarction
- Dual Antiplatelet Therapy
- Prasugrel based short DAPT
- +3 more
-
Dordrecht, Netherlands
- +2 more
Aug 5, 2022
Acute Coronary Syndrome Trial (Drug-coated stent, Drug-eluting stent)
Not yet recruiting
- Acute Coronary Syndrome
- Drug-coated stent
- Drug-eluting stent
- (no location specified)
Apr 7, 2022
Atrial Fibrillation, Atrial Appendage, Hemorrhage Trial in Paris (Rivaroxaban 10 mg qd, Rivaroxaban 15 mg qd, DAPT)
Completed
- Atrial Fibrillation
- +2 more
- Rivaroxaban 10 mg qd
- +2 more
-
Paris, FranceInstitut de Cardiologie - Hôpital Pitié-Salpêtrière
Dec 20, 2021